We would love to hear your thoughts about our site and services, please take our survey here.
With Oxford Nanopore announcing they've just raised �100m, it appears there's a lot of people convinced there's a lot legs in that business. And while it might take a few years yet, if they hit pay dirt, so do we. If we can get Tissue Regenix and Ceres into profits around the same time I'll be a very happy many on three fronts.
Another success story for stem cell - and this time in an area (correcting vision) where we are actively engaged too. http://www.bbc.co.uk/news/health-43458365 - too much to hope we might get some statement about this I suppose.
I've no further insight really, but I suspect slow news flow just about sums it up. I trust we're now just hunkered down doing the hard yards with OEMs to get everything sorted before a domestic machine launch. No reason to think the commercial arm is not progressing adequately - for example I saw a press report today that we've signed an agreement to distribute and service our products in South Africa, which could be an important market with Cape Town in particular being an extremely water-stressed area. I'm confident a little good news would send this back over 200 fairly swiftly.
Well we've been asking for the new CEO to throw us some sort of bone and I suppose this is it. My very first skim-read reaction to the RNS was concern that with the name change and the distributor announcement being made together, we were effectively abandoning the wider market and heading off into a niche. So I was reassured to notice the sentence "the partnership will allow Tissue Regenix's direct sales force to maintain their focus on soft tissue regeneration". I've no grounds to make further observation about these developments but I'm reassured to a degree just to hear that the new boss is making decisions and that this seems to be linked to ongoing demand from clinicians. Looking forward to results but let's all remember we'll still be some way off making profits - I'm just hoping for some solid progress.
Me too. I bought Greggs years back on the "oh look, there's a shop with a queue" principle and done very well out it. Should have done the same with Fevertree when I saw how gin was taking off - think I assumed it was a just a branding exercise by AB Inbev or whoever rather than a small company I could buy into. Sometimes you just have to use your eyes.
Why is it weird? Maybe I've misunderstood but isn't this just like any other company doing borrowing money? In fact this way it is easy enough for holders to lend the company money at 8 per cent - better than a diluting placing only available to big guys in the city surely?
You need to open an account with Abundance, and then bid for as much as you want (there will be a minimum I suppose) - just like lending cash. The 8 per cent is an annual rate, with interest being paid twice a year and the capital returned at the end of the period. If you invest �50,000 you'll get a total of �70000 back over 5 years - about 2,000 every six months, and then you capital. I just had a look and they've raised 7 per cent of the total already today.
We now have a big ugly power station to convert though. It's all there in the RNS.
As a LTH who is still a long way short of break even here, I'm pleased but not yet over-excited by today's events. Yes its a big contract for a company our size, but I bought into a vision considerably larger than cleaning the water of a place with the population of Melton Mowbray. I had hoped the Oman desalination plant would be the proof of concept that kick started projects in all of the world's water-stressed areas, but it's not occurred. Maybe this one will do the trick but given that this took over three years to move into contracts, it may take some time before the really big changes take place. So happy trading to all you traders, and well done to MWG for bringing this one home - but now we've got to take it up a few levels.
Hadn't heard about this rather testy report from JCAP, quoted recently by Motley Fool. Seems pretty challenging but they are described as 'short sellers'. Key criticism seems to be that we don't realise our gains: �IP Group is an accounting game more than a company and has an atrocious track record of delivering bankable returns.� Would be interesting to hear how the board might counter this. https://www.fool.co.uk/investing/2018/01/21/one-neil-woodford-growth-stock-id-buy-and-one-id-sell/
It looks like the rabbit has been pulled out of the hat and into a mustard sauce for a gastropub main course. ;-)
The Washington Post picked up on our domestic machine in it's coverage of CES. We're making inroads everybody! https://www.washingtonpost.com/news/the-switch/wp/2018/01/09/snuggle-robots-and-talking-toilets-ces-2018s-wildest-gadgets/?utm_term=.8d559d943b98
Don't think we've been given any formal information so, purely out of idle curiosity, does anyone have a thought about when we might see the relevant documents published and shares reactivated? Is it even possible to make an educated guess?
"the Board of Cellcast has now concluded that it is prudent to make a provision for 100% of the Company's interest in the Lexinta fund in its full year accounts for the year ended 31 December 2017. " Well I may be talking to myself on this board but it seems the board are listening. Just to be clear, I'm not was receiving an advisors fee ;-)
Still can't find anything in the UK press about Badilla and Lexinta beyond what CLTV put in their communications, but I did find a Swiss newspaper report. The news, at least as expressed via Google translate, does not look good. The article suggests Badilla is a classic case of the charming blagger who seemed to conjure returns of 45 percent, and when he couldn't keep it going, used new investors money to fill the holes. The reports don't say it was necessarily a deliberate Ponzi from the start, maybe the poor lamb just got out of his depth. The overall bill for investors could be 30 to 50 million francs- so not exactly Behrings, but not insignificant. Still no idea whether there might be all, some or none of our money back but maybe prudent to fear the worst. https://insideparadeplatz.ch/2017/11/07/anleger-befuerchten-ein-ponzi-zug-von-30-mio/
As I understood it last year was 11 months because we changed from end of January to end of December accounting period. So this year's results (when they come, it wasn't til June last year), will be 12 months - December to December. Will be interesting anyway though not as interesting as 2018 and certainly not as exciting as 2019. But we're heading in the right direction - and yes a juicy titbit from the CEO in the New Year would not go amiss.